Neglected Disease(s)   Technologies Available for Licensing from NIH/FDA No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time. Technologies Available for Licensing from Non-Profit Institutions Leprosy Dana-Farber Cancer Institute Inhibitors Of P. Carinii: Dihydrofolate Reductase With Marked Improved In Potency Relative To Trimethoprim And Species Selectivity Relative To Piritrexim Massachusetts General Hospital Photosensitizer Conjugates For Targeting Intracellular Pathogens Bacterial Infections Overview Buruli ulcer Cholera Leprosy Trachoma Tuberculosis Yaws

Note that this site uses cookies, Click here for more information.